EGFR Patient Gateway
LATEST UPDATES
-
FDA Approves New Treatment Option: Osimertinib Plus Chemotherapy for EGFR+ NSCLC
The US Food and Drug Administration (FDA) approved a new treatment option for people diagnosed with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors... -
Caregivers: Planning the Self-Care Journey
Join us for a Facebook Live event to understand the phases of the caregiving cycle and to learn tips and strategies for meeting the challenges of each phase. This event features... -
HOPE Summit 2024 in Atlanta, GA
Registration is now open for patients, caregivers, and their families! Join us for this free event in Atlanta, GA, May 3-5, 2024. HOPE Summit is a unique weekend conference for...